4.5 Article

Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients

期刊

ANNALS OF HEMATOLOGY
卷 100, 期 4, 页码 891-901

出版社

SPRINGER
DOI: 10.1007/s00277-020-04379-7

关键词

Curcumin; Curcuminoids; Inflammation; Iron overload; Oxidative stress; Thalassemia

资金

  1. Agricultural Research Development Agency (Public Organization) or ARDA, Thailand [CRP5805020140]

向作者/读者索取更多资源

The study demonstrates that curcuminoids have significant therapeutic effects on non-transfused beta-thalassemia/Hb E patients, including reducing oxidative stress, hypercoagulability, and inflammation markers levels, especially in the 1000 mg/day dosage group. Furthermore, the baseline ferritin levels also impact the efficacy of curcuminoids supplementation.
Curcuminoids, polyphenol compounds in turmeric, possess several pharmacological properties including antioxidant, iron-chelating, and anti-inflammatory activities. Effects of curcuminoids in thalassemia patients have been explored in a limited number of studies using different doses of curcuminoids. The present study aims to evaluate the effects of 24-week curcuminoids supplementation at the dosage of 500 and 1000 mg/day on iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfused beta-thalassemia/Hb E patients. In general, both curcuminoids dosages significantly lowered the levels of oxidative stress, hypercoagulability, and inflammatory markers in the patients. In contrast, reductions in iron parameter levels were more remarkable in the 1000 mg/day group. Subgroup analysis revealed that a marker of hypercoagulability was significantly decreased only in patients with baseline ferritin <= 1000 ng/ml independently of curcuminoids dosage. Moreover, the alleviation of iron loading parameters was more remarkable in patients with baseline ferritin > 1000 ng/ml who receive 1000 mg/day curcuminoids. On the other hand, the responses of oxidative stress markers were higher with 500 mg/day curcuminoids regardless of baseline ferritin levels. Our study suggests that baseline ferritin levels should be considered in the supplementation of curcuminoids and the appropriate curcuminoids dosage might differ according to the required therapeutic effect. Thai Clinical Trials Registry (TCTR): TCTR20200731003; July 31, 2020 retrospectively registered

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据